Aurora Cannabis (TSXV: ACB) vs. Aphria (TSX: APH): Which is the Better Buy?

Can either Aphria Inc. (TSE:APH) or Aurora Cannabis Inc. (CVE:ACB) surpass Canopy Growth Corp. (TSE:WEED)?

Motley Fool Canada | April 24, 2017: In this article, we will discuss two up-and-coming Canadian cannabis producers looking to revolutionize the marijuana industry. Aphria Inc. (TSX: APH) and Aurora Cannabis Inc. (TSXV: ACB) have taken steps to grow their brands and mop up more market share of late.

As most marijuana enthusiasts and investors know, the top spot in the cannabis industry belongs to the incumbent Canopy Growth Corp. (TSX: WEED). With a market capitalization of over $1.5 billion, Canopy has taken advantage of its branding, early Health Canada approvals for sale and export, and a first-mover position in the market to become the dominant force in the industry of late.

Win Big With Our Small Cap Picks


Currently, Canopy leads the pack in terms of the number of square feet of production space among its peers with 650,000 square feet available and another 300,000 square feet planned as additions to its base.

The only two companies with the scope, scale, and differentiation abilities to take on a giant like Canopy are Aphria and Aurora. Each company produces marijuana differently and in different parts of the country, enabling the individual companies to better focus on gaining market share in their respective “home turf,” while making Canopy’s job to remain number one a difficult one.

Aphria Inc.

Aphria’s greenhouse facilities in Leamington, Onatrio, are one of the differentiating factors behind its growth model. While other cannabis producers use greenhouses, Aphria grows 100% of its product using natural sunlight — a selling point for even the most earth-conscious consumer. Aphria’s facility is set to be expanded to 900,000 square feet; that’s enough square footage to officially take on Canopy and challenge for top spot in the Canadian market.

Aurora Cannabis Inc.

Aurora has been busy with a massive production expansion of its own, but in a different way than its competitors. Aurora’s selling point to investors has been the prototype for its new Aurora Sky facility, which promises to revolutionize the way marijuana is grown.

The production plan Aurora has put forward would result in a slightly smaller facility (approximately 800,000 square feet), boasting production efficiencies of nearly double those of Aphria or Canopy. Such cost-reduction and margin-producing initiatives have positioned Aurora as the potential king of profitability in an industry that is soon to be bombarded with supply.

Related: Aurora Cannabis Stock (CVE:ACB) Continues to Smoke, But Where’s the Risk?

[Editor’s Note: Since it received its Marijuana for Medical Purposes Regulations license, in November 2015, and first started selling as of January 5th, 2016, the Aurora Cannabis stock has seemed to have no setbacks but such operational flow may not be sustainable. With the first 200,000 square foot phase of the new 600,000 square foot facility expected to be completed and operational by the summer of 2017, any delay in construction that may result from inclement weather, which is common in Alberta, could disrupt Aurora’s ability to meet its growing demand, and investors’ expectations. Aurora Cannabis announced recently that it will increase the size of its previously announced bought deal private placement of convertible debentures to C$75 million. Aurora Cannabis added that net proceeds from the Offering will be used primarily towards international expansion and growth opportunities.]

The bottom line

We are a believer in the power of a differentiation advantage as well as a cost advantage. Our take on this industry is this: while it may still be considered “niche” as a whole and not yet fully matured or conventional, when the time comes for these three major players to carve out their territories and begin marketing to the masses, the race is on.


Disclosure: Neither any of the principals at Small Cap Power, nor their family members, own shares in any of the companies mentioned above.

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: